148 related articles for article (PubMed ID: 30549068)
1. Determination of olanzapine for therapeutic drug monitoring in schizophrenia patients by LC/MS method.
Albayrak M; Kadioglu Y; Yaman ME; Senol O; Oral E
Biomed Chromatogr; 2019 Apr; 33(4):e4468. PubMed ID: 30549068
[TBL] [Abstract][Full Text] [Related]
2. Supported liquid extraction and LC-MS-MS determination of iloperidone and olanzapine in rat plasma: Application to a pharmacokinetic study.
Gangu Naidu C; Nageswara Rao R; Prasada Rao AV; Nagesh Kumar K; Padiya R; Madhusudhan Rao V
J Chromatogr Sci; 2018 Nov; 56(10):879-887. PubMed ID: 29982313
[TBL] [Abstract][Full Text] [Related]
3. Monitoring of olanzapine in serum by liquid chromatography-atmospheric pressure chemical ionization mass spectrometry.
Bogusz MJ; Krüger KD; Maier RD; Erkwoh R; Tuchtenhagen F
J Chromatogr B Biomed Sci Appl; 1999 Sep; 732(2):257-69. PubMed ID: 10517347
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous Determination of Antipsychotic Drugs and Their Active Metabolites by LC-MS-MS and its Application to Therapeutic Drug Monitoring.
Miroshnichenko II; Baymeeva NV
J Chromatogr Sci; 2018 Jul; 56(6):510-517. PubMed ID: 29635397
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a liquid chromatography-isotope dilution tandem mass spectrometry for determination of olanzapine in human plasma and its application to bioavailability study.
Zhang MQ; Jia JY; Lu C; Liu GY; Yu CY; Gui YZ; Liu Y; Liu YM; Wang W; Li SJ; Yu C
Yao Xue Xue Bao; 2010 Jun; 45(6):767-71. PubMed ID: 20939188
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous analysis of olanzapine, fluoxetine, and norfluoxetine in human plasma using liquid chromatography-mass spectrometry and its application to a pharmacokinetic study.
Ni XJ; Wang ZZ; Shang DW; Lu HY; Zhang M; Wen YG
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Aug; 1092():506-514. PubMed ID: 30008307
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a sensitive liquid chromatography/electrospray tandem mass spectrometry assay for the quantification of olanzapine in human plasma.
Nirogi RV; Kandikere VN; Shukla M; Mudigonda K; Maurya S; Boosi R; Yerramilli A
J Pharm Biomed Anal; 2006 Jun; 41(3):935-42. PubMed ID: 16504450
[TBL] [Abstract][Full Text] [Related]
8. Development of a fast LC-MS/MS assay for the determination of deferiprone in human plasma and application to pharmacokinetics.
Song TS; Hsieh YW; Peng CT; Liu CH; Chen TL; Hour MJ
Biomed Chromatogr; 2012 Dec; 26(12):1575-81. PubMed ID: 22457166
[TBL] [Abstract][Full Text] [Related]
9. Determination of olanzapine in human blood by liquid chromatography-tandem mass spectrometry.
Berna M; Ackermann B; Ruterbories K; Glass S
J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Feb; 767(1):163-8. PubMed ID: 11863288
[TBL] [Abstract][Full Text] [Related]
10. DEVELOPMENT OF LC-MS/MS METHOD FOR DETERMINATION OF THE OLANZAPINE IN HUMAN PLASMA.
Sivsivadze K; Jokhadze M; Tushurashvili P; Murtazashvili T; Imnadze N
Georgian Med News; 2017 Feb; (263):118-125. PubMed ID: 28452738
[TBL] [Abstract][Full Text] [Related]
11. Determination of 3-hydroxy pterocarpan, a novel osteogenic compound in rat plasma by liquid chromatography-tandem mass spectrometry: application to pharmacokinetics study.
Manickavasagam L; Gupta S; Mishra S; Kumar A; Raghuvanshi A; Goel A; Singh D; Jain GK
Biomed Chromatogr; 2011 Jul; 25(7):843-50. PubMed ID: 20963772
[TBL] [Abstract][Full Text] [Related]
12. Determination of olanzapine in human plasma by reversed-phase high-performance liquid chromatography with ultraviolet detection.
D'Arrigo C; Migliardi G; Santoro V; Spina E
Ther Drug Monit; 2006 Jun; 28(3):388-93. PubMed ID: 16778724
[TBL] [Abstract][Full Text] [Related]
13. Quantitative determination of atenolol in dried blood spot samples by LC-HRMS: a potential method for assessing medication adherence.
Lawson G; Cocks E; Tanna S
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 May; 897():72-9. PubMed ID: 22552005
[TBL] [Abstract][Full Text] [Related]
14. Optimized UPLC-MS/MS method for the quantitation of olanzapine in human plasma: application to a bioequivalence study.
Du P; Li P; Zhao R; Liu H; Liu L
Bioanalysis; 2019 Jun; 11(13):1291-1302. PubMed ID: 31379195
[No Abstract] [Full Text] [Related]
15. [Determination of risperidone in human plasma by liquid chromatography-tandem mass spectrometry].
Duan XT; Chen XY; Zhang YF; Zhong DF
Yao Xue Xue Bao; 2006 Jul; 41(7):684-8. PubMed ID: 17007366
[TBL] [Abstract][Full Text] [Related]
16. Determination of abacavir, tenofovir, darunavir, and raltegravir in human plasma and saliva using liquid chromatography coupled with tandem mass spectrometry.
Yamada E; Takagi R; Sudo K; Kato S
J Pharm Biomed Anal; 2015 Oct; 114():390-7. PubMed ID: 26112927
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of a rapid LC-MS/MS method to quantify letrozole in human plasma and its application to therapeutic drug monitoring.
Shao R; Yu LY; Lou HG; Ruan ZR; Jiang B; Chen JL
Biomed Chromatogr; 2016 Apr; 30(4):632-7. PubMed ID: 26317321
[TBL] [Abstract][Full Text] [Related]
18. Validation of a sensitive LC/MS/MS method for simultaneous quantitation of flupentixol and melitracene in human plasma.
Che J; Meng Q; Chen Z; San C; Hou Y; Cheng Y
J Pharm Biomed Anal; 2007 Dec; 45(5):785-92. PubMed ID: 17881181
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of LC-MS/MS method for simultaneous determination of sofosbuvir and daclatasvir in human Plasma: Application to pharmacokinetic study.
Abdallah OM; Abdel-Megied AM; Gouda AS
Biomed Chromatogr; 2018 Jun; 32(6):e4186. PubMed ID: 29314090
[TBL] [Abstract][Full Text] [Related]
20. LC-MS/MS method for the determination of clodronate in human plasma.
Hasan M; Schumacher G; Seekamp A; Taedken T; Siegmund W; Oswald S
J Pharm Biomed Anal; 2014 Nov; 100():341-347. PubMed ID: 25194348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
